//
Scott R Mackenzie Foundation Inc. is a private corporation based in JACKSONVILLE, FL. The foundation received its IRS ruling in 2014. It holds total assets of $12.7M. Annual income is reported at $4.3M. The foundation operates in the area of philanthropy & grantmaking. According to available records, Scott R Mackenzie Foundation Inc. has made 18 grants totaling $3.1M, with a median grant of $142K. Annual giving has grown from $939K in 2020 to $1.2M in 2022. Individual grants have ranged from $10K to $450K, with an average award of $175K. The foundation has supported 9 unique organizations. The foundation primarily supports organizations in Florida, Maine, Ohio, which account for 83% of all grants. Grantmaking reaches organizations across 5 states. Contributions to this foundation are tax-deductible.
Scott R Mackenzie Foundation Inc. primarily funds organizations in the area of philanthropy & grantmaking. Based on available records, the foundation has funded 18 grants. Its grantmaking reaches organizations primarily in FL, ME, OH.
Scott R Mackenzie Foundation Inc. has distributed a total of $3.1M across 18 grants. The median grant size is $142K, with an average of $175K. Individual grants have ranged from $10K to $450K.
The application deadline is INITIAL GRANT APPLICATION: APRIL 30TH; FINAL GRANT APPLICATION: JUNE 30TH. FUNDING IS AVAILABLE FOR AMERICAN-BASED ORGANIZATIONS WITH A MISSION TO FIND A CURE FOR: CANCER LUNG DISEASE (INCLUDING ASTHMA) DIABETES HEART DISEASE.
Scott R Mackenzie Foundation Inc. is headquartered in JACKSONVILLE, FL. While based in FL, the foundation distributes grants to organizations across 5 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Carolyn Tucker | EXEC. DIRECTOR | $15K | $0 | $15K |
| Gerardo Cruz | DIRECTOR | $15K | $0 | $15K |
| Lawrence B Mackenzie | DIRECTOR | $15K | $0 | $15K |
| Melinda A Mackenzie | DIRECTOR | $15K | $0 | $15K |
| Paula Sprague | DIRECTOR | $15K | $0 | $15K |
Total Giving
$1.5M
Total Assets
$13.8M
Fair Market Value
$20.1M
Net Worth
$13.8M
Grants Paid
$1.2M
Contributions
$0
Net Investment Income
$172K
Distribution Amount
$1.1M
Total: $4.2M
Total Grants
18
Total Giving
$3.1M
Average Grant
$175K
Median Grant
$142K
Unique Recipients
9
Most Common Grant
$125K
of 2022 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Florida InternationalTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE FUNDS TO SUPPORT CHARACHERIZING SARCOMA MUTATIONS WITH MATCHING DRUGS AND APPROPRIATE TARGETED TREATMENTS BY IMPLEMENTING A COMBINED FUNCTIONAL DRUG SCREENING AND GENOMICS PLATFORM AND SELECTING CLINICALLY APPROVED COMPOUNDS TO OFFER ADVANCED SARCOMA PATIENTS THE SAFEST POSSIBLE CHANCE OF ACHIEVING REMISSIONS AND ULTIMATELY CURING THEIR DISEASE. | Miami, FL | $350K | 2020 |
| Mount Desert Island Biological LaboratoryTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO SEEK TO PREVENT ORGAN COMPLICATIONS IN DIABETIC PATIENTS. HIGH GLUCOSE LEVELS LEAD TO THE PATHOLOGICAL CHANGES IN THE VASCULATURE OF DIFFERENT ORGANS SUCH AS THE HEART, KIDNEY, EYE AND PERIPHERAL CIRCULATION. THE FOCUS IS THE MICROCIRCULATION OF THE KIDNEY. THE ENDOTHELIAL CELL SURFACE IS COVERED WITH A LAYER OF GLYCOCALYX. THE GLYCOCALYX IS VERY IMPORTANT FOR THE HEALTH OF THE VASCULAR WALL AND REGULATES CENTRAL MECHANISMS SUCH AS METABO | Bar Harbor, ME | $450K | 2022 |
| Cincinnati Cancer Foundation IncTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO ESTABLISH THE ADVANCING PRECISION ONCOLOGY CENTER ("APOC"), WHOSE PURPOSE IS TO ENABLE PATIENT ACCESS TO A WIDE RANGE OF NGS TESTING INTENDED TO FACILITATE EARLY DETECTION, BETTER OUTCOMES, AND BETTER POSSIBILITIES FOR CANCER CURES THROUGH EARLIER DETECTION AND INTERVENTION. |
WEST PALM BCH, FL
WEST PALM BCH, FL
POMPANO BEACH, FL
| Scott R Mackenzie |
| DIRECTOR |
| $0 |
| $0 |
| $0 |
| 2017 | 990PF | View |
| 2016 | 990PF | View |
| Cincinnati, OH |
| $350K |
| 2022 |
| University Of ArizonaTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO SEEK TO IMPROVE THE DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION. TODEVELOP PATIENT-SPECIFIC TARGETED NEXT-GENERATION GENE SEQUENCING FOR PREDICTING AND DIAGNOSING ATRIAL FIBRILLATION AND ESTABLISH A PATIENT-SPECIFIC STEM CELL PLATFORM FOR DEVELOPING PRECISION MEDICINE BASED TREATMENTS. | Tucson, AZ | $175K | 2022 |
| The Jackson LaboratoryTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO INVESTIGATE AGING-RELATED RNA SPLICING ALTERATIONS TO REVEAL NOVEL BIOMARKERS FOR QUANTIFYING BREAST CANCER RISK AND NEW TARGETS FOR TREATING BREAST CANCER. | Bar Harbor, ME | $135K | 2022 |
| University Of Florida FoundationTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO SEEK TO TEST GENETIC ASSOCIATIONS WITH CHILDREN'S RESPONSE TO ALBUTEROL AND BEGIN A LONGITUDINAL PEDIATRIC ASTHMA REGISTRY COMBINING CLINICAL AND GENOMIC DATA. | Gainesville, FL | $58K | 2022 |
| Mayo ClinicTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THIS GIFT TO SUPPORT THE TAPESTRY STUDY. | Jacksonville, FL | $33K | 2022 |
| Israel Cancer Research FundTHE BENEFACTOR DESIRES THAT GRANTEE SHALL USE THE GIFT TO ASK HOW DNA REPAIR IS ORCHESTRATED DESPITE THE PACKAGING OF DNA INTO CHROMATIN. SWI/SNF PROTEINS ESTABLISH AND MAINTAIN CHROMATIN STRUCTURE. SUBUNITS OF SWI/SNF PROTEINS ARE MUTATED IN 20% OF CANCERS, IMPLICATING THEM IN CARCINOGENESIS, AND MAKING THEM ATTRACTIVE CANDIDATES FOR CANCER-SPECIFIC AND SELECTIVE THERAPIES. DR. ADAR EXPECTS TO ESTABLISH THAT SWI/SNF REMODELERS FACILITATE SPECIFIC STEPS IN NUCLEOTIDE EXCISION REPAIR (NER) IN CHR | New York, NY | $149K | 2021 |
| University Of North FloridaTHE BENEFACTOR DESIRES THAT THE GRANTEE SHALL USE THE GIFT TO SUPPORT A 16 WEEK STUDY ON THE EFFECT OF FERMENTED FOODS ON THE GUT MICROBIOTA FOR PREVENTION OF CARDIOVASCULAR DISEASE TO HELP REDUCE THE MORTALITY RATE OF CARDIOVASCULAR DISEASE. | Jacksonville, FL | $128K | 2020 |
© 2026 Granted AI